You are here

Article Text

Article menu
Download PDFPDF
Mailbox
Suggestion for IL-2 treatment of conjunctival squamous carcinoma
  1. JAN-WILLEM KOTEN,
  2. WILLEM DEN OTTER
  1. Department of Cell Biology and Histology
  2. Utrecht University, Utrecht, Netherlands
  1. Willem Den Otter, Department of Cell Biology and Histology, Utrecht University, PO Box 80.176, 3508 TD, Utrecht, Netherlands.

https://doi.org/10.1136/bjo.83.8.994b

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Editor,—We refer to a recent publication of Poole,1 discussing the incidence of conjunctival squamous carcinoma in Tanzania, notably in HIV affected patients. We have extensively studied a similar condition (bovine ocular squamous carcinoma) with a comparable genesis in veterinary cases, in the Harare area (Zimbabwe).2 We treated such cases with intralesional IL-2 injections of 200 000 U IL-2 (Chiron) over 10 days. A large number of remissions and in …

    View Full Text